GEHC Key Statistics, Chart & Performance
The current stock price of GEHC is 83.61 USD. In the past month the price increased by 3.7%. In the past year, price increased by 5.16%.
GEHC Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.02 | 217.08B | ||
| ISRG | INTUITIVE SURGICAL INC | 67.11 | 204.83B | ||
| BSX | BOSTON SCIENTIFIC CORP | 32.56 | 142.40B | ||
| SYK | STRYKER CORP | 26.9 | 135.46B | ||
| BDX | BECTON DICKINSON AND CO | 13.62 | 56.04B | ||
| IDXX | IDEXX LABORATORIES INC | 54.6 | 54.98B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.79 | 50.40B | ||
| RMD | RESMED INC | 24.72 | 35.73B | ||
| DXCM | DEXCOM INC | 36.33 | 26.35B | ||
| PODD | INSULET CORP | 63.16 | 20.31B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.22 | 17.99B | ||
| HOLX | HOLOGIC INC | 17.45 | 16.61B |
Related stock screener links
About GEHC
Company Profile
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 53,000 full-time employees. The company went IPO on 2022-12-15. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
Company Info
GE HEALTHCARE TECHNOLOGY
500 West Monroe Street
Chicago ILLINOIS US
Employees: 53000
Phone: 18337351139
GE HEALTHCARE TECHNOLOGY / GEHC FAQ
What does GEHC do?
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 53,000 full-time employees. The company went IPO on 2022-12-15. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
What is the stock price of GE HEALTHCARE TECHNOLOGY today?
The current stock price of GEHC is 83.61 USD. The price increased by 0.26% in the last trading session.
Does GE HEALTHCARE TECHNOLOGY pay dividends?
GE HEALTHCARE TECHNOLOGY (GEHC) has a dividend yield of 0.17%. The yearly dividend amount is currently 0.12.
What is the ChartMill rating of GE HEALTHCARE TECHNOLOGY stock?
GEHC has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Which stock exchange lists GEHC stock?
GEHC stock is listed on the Nasdaq exchange.
Would investing in GE HEALTHCARE TECHNOLOGY be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on GEHC.
Can you provide the number of employees for GE HEALTHCARE TECHNOLOGY?
GE HEALTHCARE TECHNOLOGY (GEHC) currently has 53000 employees.
GEHC Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to GEHC. When comparing the yearly performance of all stocks, GEHC is one of the better performing stocks in the market, outperforming 70.89% of all stocks.
GEHC Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to GEHC. GEHC scores excellent on profitability, but there are concerns on its financial health.
GEHC Financial Highlights
Over the last trailing twelve months GEHC reported a non-GAAP Earnings per Share(EPS) of 4.59. The EPS increased by 8.77% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.95% | ||
| ROA | 6.14% | ||
| ROE | 22.19% | ||
| Debt/Equity | 0.83 |
GEHC Forecast & Estimates
28 analysts have analysed GEHC and the average price target is 91.51 USD. This implies a price increase of 9.45% is expected in the next year compared to the current price of 83.61.
For the next year, analysts expect an EPS growth of 2.67% and a revenue growth 4.16% for GEHC